Literature DB >> 25267424

Ethnicity and sympathetic tone: predictors of the blood pressure response to renal denervation?

Yutang Wang1.   

Abstract

Mesh:

Year:  2014        PMID: 25267424     DOI: 10.1038/nrcardio.2014.70-c1

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  21 in total

1.  Renal denervation in moderate to severe CKD.

Authors:  Dagmara Hering; Felix Mahfoud; Antony S Walton; Henry Krum; Gavin W Lambert; Elisabeth A Lambert; Paul A Sobotka; Michael Böhm; Bodo Cremers; Murray D Esler; Markus P Schlaich
Journal:  J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 10.121

2.  Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery.

Authors:  Masaomi Chinushi; Daisuke Izumi; Kenichi Iijima; Katsuya Suzuki; Hiroshi Furushima; Osamu Saitoh; Yui Furuta; Yoshifusa Aizawa; Mitsuya Iwafuchi
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

3.  Hypertension: How should data from SYMPLICITY HTN-3 be interpreted?

Authors:  Roland E Schmieder
Journal:  Nat Rev Cardiol       Date:  2014-05-20       Impact factor: 32.419

4.  Catheter-based renal denervation for treatment of resistant hypertension.

Authors:  Henrik Vase; Ole Norling Mathiassen; Anne Kaltoft; Erling Bjerregaard Pedersen; Kent Lodberg Christensen; Niels Henrik Buus; Ole Lederballe; Jens Flensted Lassen; Hans Erik Bøtker; Leif Thuesen
Journal:  Dan Med J       Date:  2012-06       Impact factor: 1.240

5.  Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series.

Authors:  Julia Brinkmann; Karsten Heusser; Bernhard M Schmidt; Jan Menne; Gunnar Klein; Johann Bauersachs; Hermann Haller; Fred C Sweep; Andre Diedrich; Jens Jordan; Jens Tank
Journal:  Hypertension       Date:  2012-10-08       Impact factor: 10.190

6.  Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trial.

Authors:  John A Ormiston; Timothy Watson; Niels van Pelt; Ralph Stewart; James T Stewart; Jonathon M White; Robert N Doughty; Fiona Stewart; Rhona Macdonald; Mark W I Webster
Journal:  EuroIntervention       Date:  2013-05-20       Impact factor: 6.534

7.  Drug-resistant hypertensive patients responding to multielectrode renal denervation exhibit improved heart rate dynamics and reduced arrhythmia burden.

Authors:  C Tsioufis; V Papademetriou; D Tsiachris; K Dimitriadis; A Kasiakogias; A Kordalis; V Antonakis; A Kefala; C Thomopoulos; I Kallikazaros; E O-Y Lau; C Stefanadis
Journal:  J Hum Hypertens       Date:  2014-03-13       Impact factor: 3.012

8.  Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension.

Authors:  Mustafa Ezzahti; Adriaan Moelker; Edith C H Friesema; Nicole A J van der Linde; Gabriel P Krestin; Anton H van den Meiracker
Journal:  J Hypertens       Date:  2014-01       Impact factor: 4.844

9.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

10.  SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?

Authors:  Hitesh C Patel; Carl Hayward; Carlo Di Mario
Journal:  Glob Cardiol Sci Pract       Date:  2014-01-29
View more
  2 in total

Review 1.  Carotid baroreflex activation therapy for resistant hypertension.

Authors:  Ronald G Victor
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

2.  Renal denervation--a valid treatment option despite SYMPLICITY HTN-3.

Authors:  Roland E Schmieder
Journal:  Nat Rev Cardiol       Date:  2014-09-30       Impact factor: 32.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.